Product Images Teriflunomide

The text appears to be a table with details about the percentage of disability progression sustained for 12 weeks with different treatments. The table shows the number at risk and the percentage of disability progression for Plcsbo, 7mg Teriflunomide Tablets, and 14mg Terflunomide Tablets. It is not clear what the numbers under "o" and "(@" refer to.*

This appears to be a medical or pharmaceutical table showing the effectiveness of different tablets in sustaining disability progression for a period of 12 weeks. The tablets are labeled with doses of 7mg and 14mg Terflunomide. The table also includes a placebo group. The number of subjects in each group is shown, as is the percentage of subjects who experienced sustained disability progression during the 12-week period of the study.*

Teriflunomide tablets with NDC 0378-0627-93 is a medication that comes in a bottle with 30 film-coated tablets. Pharmacist must dispense medication guide to each patient. It is manufactured by Mylan Pharmaceuticals in Morgantown, WV. It should be stored at room temperature, kept tightly sealed out of reach of children, and protected from light. Recommended dosage is one tablet per day or as prescribed. Further prescription information should be obtained from the accompanying literature.*

Teriflunomide tablets are a prescription medication with a National Drug Code of 0378-0628-03. The usual dosage is one tablet taken orally once daily. It is advised to dispense the accompanying medication guide to each patient. It is recommended to store this medication at a controlled room temperature between 20 to 25 degrees Celsius and to keep it in a tight light-resistant container. Each film-coated tablet contains Teriflunomide 14mg.*